These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1146 related items for PubMed ID: 18340011

  • 1. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
    Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, Cooper J, Weiser-Evans MC.
    Circ Res; 2008 May 09; 102(9):1036-45. PubMed ID: 18340011
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
    Furgeson SB, Simpson PA, Park I, Vanputten V, Horita H, Kontos CD, Nemenoff RA, Weiser-Evans MC.
    Cardiovasc Res; 2010 May 01; 86(2):274-82. PubMed ID: 20051384
    [Abstract] [Full Text] [Related]

  • 3. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.
    Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krotz F, Sohn HY, Klauss V, Weber C, Schober A.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2540-7. PubMed ID: 17932320
    [Abstract] [Full Text] [Related]

  • 4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):765-72. PubMed ID: 16456092
    [Abstract] [Full Text] [Related]

  • 5. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.
    Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Möpps B, Mericskay M, Gierschik P, Biessen EA, Weber C.
    Circ Res; 2005 Apr 15; 96(7):784-91. PubMed ID: 15761195
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y.
    Arterioscler Thromb Vasc Biol; 2015 Jan 15; 35(1):175-83. PubMed ID: 25378413
    [Abstract] [Full Text] [Related]

  • 7. Local CXCR4 Upregulation in the Injured Arterial Wall Contributes to Intimal Hyperplasia.
    Shi X, Guo LW, Seedial S, Takayama T, Wang B, Zhang M, Franco SR, Si Y, Chaudhary MA, Liu B, Kent KC.
    Stem Cells; 2016 Nov 15; 34(11):2744-2757. PubMed ID: 27340942
    [Abstract] [Full Text] [Related]

  • 8. Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor.
    Pan CH, Chen CW, Sheu MJ, Wu CH.
    Vascul Pharmacol; 2012 Nov 15; 56(1-2):98-105. PubMed ID: 22166584
    [Abstract] [Full Text] [Related]

  • 9. SDF-1α induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation.
    Nemenoff RA, Horita H, Ostriker AC, Furgeson SB, Simpson PA, VanPutten V, Crossno J, Offermanns S, Weiser-Evans MC.
    Arterioscler Thromb Vasc Biol; 2011 Jun 15; 31(6):1300-8. PubMed ID: 21415388
    [Abstract] [Full Text] [Related]

  • 10. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
    Schober A, Knarren S, Lietz M, Lin EA, Weber C.
    Circulation; 2003 Nov 18; 108(20):2491-7. PubMed ID: 14581398
    [Abstract] [Full Text] [Related]

  • 11. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.
    Kobayashi K, Sato K, Kida T, Omori K, Hori M, Ozaki H, Murata T.
    Arterioscler Thromb Vasc Biol; 2014 Aug 18; 34(8):1716-22. PubMed ID: 24925969
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G, Markart P, Dahal BK, Kojonazarov B, Marsh LM, Schermuly RT, Taube C, Meinhardt A, Ghofrani HA, Steinhoff M, Seeger W, Preissner KT, Olschewski A, Weissmann N, Wygrecka M.
    Circ Res; 2012 Apr 27; 110(9):1179-91. PubMed ID: 22461388
    [Abstract] [Full Text] [Related]

  • 18. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y, Yokoyama U, Yanai C, Ishige R, Kurotaki D, Umemura M, Fujita T, Kubota T, Okumura S, Sata M, Tamura T, Ishikawa Y.
    Arterioscler Thromb Vasc Biol; 2015 Dec 27; 35(12):2617-25. PubMed ID: 26427796
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C, Zakrzewicz D, Dahal BK, Bálint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N, Kwapiszewska G.
    Thromb Haemost; 2014 Dec 27; 112(6):1288-303. PubMed ID: 25231004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.